Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Looking Past Aduhelm, Biogen Puts Pipeline On Display
Data Expected From Six Trials For Five Drugs Through 2022
Sep 22 2021
•
By
Mandy Jackson
Biogen highlighted neuroscience programs in Alzheimer's, ALS, depression and schizophrenia • Source: Alamy
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Strategy
More from Business